Quick Heal Technologies Limited (QUICKHEAL)

About

Quick Heal Technologies operates in Software Products, a ₹808 Cr market-cap player in India's IT software sector. Operating margin swung from +11.24% (Sep 2025) to -60% (Mar 2026), signalling acute operational distress in recent quarters.

Face value: ₹10

Market cap

₹749 Cr

P/E

—

P/B

1.7×

Dividend yield

2.2%

ROE

-2.5%

ROCE

-4.6%

Debt / equity

0

OPM

-11.3%

EPS (TTM)

₹-2.0

Book value

₹80.5

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Revenue halved from ₹83.52 Cr (Sep 2025) to ₹44.99 Cr (Jun 2026); net losses widened to -₹5–20 Cr/quarter vs +₹8 Cr profit nine months earlier — root cause of collapse unexplained.
Operating margin deteriorated from +11.24% to -59.95% in six months; ROE -2.49%, EPS negative (-₹0.91 to -₹3.58), and stock down 49.73% in one year signal investor loss of confidence.
Software products compete against free alternatives (OS-built security) and established global players; verify Quick Heal's differentiated positioning, customer base, and product roadmap.
Commoditization pressure, customer churn risk, and dependence on recurring-revenue retention are sector-wide headwinds — verify subscription adoption rates and customer retention trends.

Generated analysis · source review pending

Growth drivers

Sep 2025 achieved +11.24% OPM on ₹83.52 Cr revenue with ₹8 Cr profit, proving operability; if operational issues that triggered Mar–Jun 2026 losses are resolved, path to profitability exists.
Zero debt (D/E 0) eliminates leverage drag and provides capital flexibility for product investment or market expansion if recovery plan solidifies.
Cyber and data-protection regulatory environment in India expanding — verify if Quick Heal's product roadmap aligns with new compliance needs and if company can capture this growth.
Promoter 71.48% stake combined with zero debt means capital is available for strategic investment; verify if promoter-backed turnaround or transformation plan is underway.

Generated analysis · source review pending

2,528 historical price candles were omitted because the exchange source has not been verified.

₹138.2-5.3%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)
+High promoter holding of 71.5% with no pledge

Cons

−Low return on equity of 1.4% (3-yr avg)
−Revenue shrank over the last 5 years (-4.8% a year)
−Weak interest coverage of -102.2×

Research score

Structured signal from quality, growth, valuation and momentum.

39/100

Business quality: 20
Growth: 0
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Oracle Financial Services Software LimitedOFSSOFSS	₹90,758 Cr	₹90,758 Cr	₹8,945 Cr	₹4,508 Cr	45.3%	₹3,413 Cr	34.4%	42.1%	32.6%	56
Tanla Platforms LimitedTANLATANLA	₹6,468 Cr	₹6,468 Cr	₹4,603 Cr	₹761 Cr	16.4%	₹533 Cr	11.5%	26.3%	21.4%	15
C.e. Info Systems LimitedMAPMYINDIAMAPMYINDIA	₹4,635 Cr	₹4,635 Cr	₹492 Cr	₹176 Cr	37%	₹138 Cr	28.3%	22.9%	15.8%	-138
Capillary Technologies India LimitedCAPILLARYCAPILLARY	₹4,410 Cr	₹4,455 Cr	₹735 Cr	₹93 Cr	12.6%	₹52 Cr	7.1%	3%	5.1%	48
Technvision Ventures LimitedTECHNVISNTECHNVISN	₹2,371 Cr	—	₹228 Cr	₹4 Cr	1.7%	₹0 Cr	0.1%	—	—	—
Mobavenue AI Tech LtdMOBAVENUEMOBAVENUE	₹2,238 Cr	₹2,247 Cr	₹218 Cr	₹45 Cr	20.8%	₹29 Cr	13.4%	60.8%	55.5%	—
Ramco Systems LimitedRAMCOSYSRAMCOSYS	₹2,054 Cr	₹2,054 Cr	₹712 Cr	₹155 Cr	22.6%	₹42 Cr	6%	17.6%	12.6%	15
Nucleus Software Exports LimitedNUCLEUSNUCLEUS	₹1,701 Cr	₹1,701 Cr	₹869 Cr	₹100 Cr	14.3%	₹105 Cr	13.3%	18.7%	13.6%	42
Blue Cloud Softech Solutions LtdBLUECLOUDSBLUECLOUDS	₹1,497 Cr	₹1,587 Cr	₹797 Cr	₹70 Cr	8.8%	₹44 Cr	5.6%	48.8%	44.5%	52
Subex LimitedSUBEXLTDSUBEXLTD	₹1,087 Cr	₹1,087 Cr	₹292 Cr	₹39 Cr	9.2%	₹30 Cr	10.2%	11%	8.8%	86
Unicommerce Esolutions LimitedUNIECOMUNIECOM	₹928 Cr	₹928 Cr	₹211 Cr	₹32 Cr	17.3%	₹22 Cr	10%	20%	15.6%	-34
Quick Heal Technologies LimitedQUICKHEALQUICKHEAL	₹749 Cr	₹749 Cr	₹249 Cr	₹-37 Cr	-11.3%	₹-11 Cr	-4.2%	-4.6%	-2.5%	-3,095

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	315	283	333	342	278	292	280	261
COGS	3	1	12	12	9	7	7	4
Gross profit	—	—	321	330	269	285	272	257
	184	190	180	223	267	267	279	286
	128	93	141	107	2	18	-7	-29
OPM %	40.6%	32.8%	42.5%	31.3%	0.7%	6%	-2.4%	-11.3%
Depreciation	24	22	19	17	16	13	13	14
Interest	—	—	0	0	0	0	0	0
	33	31	24	19	22	21	21	23
Profit before tax	137	100	146	109	8	26	1	-21
Tax	45	27	39	25	2	2	-4	-10
Tax %	33%	26.7%	26.8%	23.5%	20.2%	7.5%	-404%	-47%
	92	74	107	83	6	24	5	-11
PAT margin %	29.2%	26%	32.1%	24.3%	2.3%	8.3%	1.8%	-4.2%
EPS (₹)	13	11.2	16.7	14	1.1	4.6	0.9	-2
EPS adjusted (₹)	—	11.5	16.7	14.3	1.2	4.5	0.9	-2
	15.3%	35.6%	24%	32.1%	219.3%	65.8%	0%	—
Annual report	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	64	64	58	53	54	54	54
Reserves	—	687	570	367	383	387	382
	—	0	0	0	0	0	0
	—	75	88	74	76	84	110
Total equity & liabilities	—	827	716	493	513	525	547
	158	146	112	100	85	84	90
CWIP	—	2	0	0	3	0	0
Investments	—	416	343	222	222	214	237
	—	263	261	171	203	226	220
Total assets	—	827	716	493	513	525	547

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	96.5%	96.4%	96.6%	97.7%	97.4%	98.4%
EBITDA margin %	40.6%	32.8%	42.5%	31.3%	0.7%	6%	-2.4%	-11.3%
EBIT margin %	33.1%	25.2%	36.6%	26.2%	-5.1%	1.7%	-7%	-16.6%
PAT margin %	29.2%	26%	32.1%	24.3%	2.3%	8.3%	1.8%	-4.2%
Working capital
Receivable days	—	—	165	184	161	165	218	192
Inventory days	—	—	105	144	176	150	114	221
Payable days	—	—	1,567	1,959	1,902	2,131	1,788	3,508
NWC days	—	—	-1,297	-1,631	-1,565	-1,817	-1,457	-3,095
Leverage
Current ratio	—	—	8.51	6.2	4.5	4.96	4.72	3.4
Debt to EBITDA	—	—	0	0	0	0	—	—
Debt to equity	—	—	0	0	0	0	0	0
Interest coverage	—	—	—	—	—	202.6	5.5	-102.2
Asset turnover	—	—	0.4	0.48	0.56	0.57	0.53	0.48
Return ratios
Return on assets %	—	—	12.9%	11.6%	1.3%	4.7%	1%	-2%
Return on capital employed %	—	—	19.4%	15.7%	1.5%	6.1%	0.3%	-4.6%
Return on equity %	—	—	14.2%	13.3%	1.5%	5.5%	1.1%	-2.5%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	73.06%	72.76%	72.48%	72.44%	72.08%	71.92%	71.82%	71.79%	71.63%	71.54%	71.5%	71.48%
	1.56%	1.66%	1.65%	1.54%	1.61%	1.81%	2.02%	1.16%	0.5%	0.45%	0.73%	0.46%
	1.13%	1.44%	2.06%	2.41%	2.62%	2.84%	2.63%	2.58%	2.33%	2.29%	1.16%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	24.25%	24.14%	23.81%	23.61%	23.69%	23.43%	23.53%	24.47%	25.54%	25.72%	26.61%	28.06%
No. of shareholders	—	—	—	—	—	—	—	—	55,910	56,030	56,399	62,251

Promoter holding down 1.58 percentage points since Sep 2023.

102 deals · 28 Sept 2023 – 2 Jun 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
2 Jun 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	3,65,192	₹191.51	₹6.99 Cr
2 Jun 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	3,11,330	₹191.59	₹5.96 Cr
19 May 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	2,76,518	₹210.18	₹5.81 Cr
19 May 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	2,67,011	₹211.87	₹5.66 Cr
13 May 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	3,89,197	₹213.70	₹8.32 Cr
13 May 2026	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	3,81,858	₹212.40	₹8.11 Cr
13 May 2026	JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	NSE	Buy	2,73,460	₹213.45	₹5.84 Cr
13 May 2026	JUNOMONETA FINSOL PRIVATE LIMITED	Bulk	NSE	Sell	2,71,963	₹213.57	₹5.81 Cr
12 May 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Buy	5,58,187	₹217.18	₹12.12 Cr
12 May 2026	NK SECURITIES RESEARCH PRIVATE LIMITED	Bulk	NSE	Sell	5,58,187	₹217.25	₹12.13 Cr

1–10 of 102

1 / 11

Mr. KAILASH SAHEBRAO KATKARExecutive Director-Chairperson related to Promoter-MD
Mr. SANJAY SAHEBRAO KATKARExecutive Director-MD
Mr. AMITABHA MUKHOPADHYAYNon-Executive - Independent Director
Mr. RICHARD DENNIS STIENNONNon-Executive - Independent Director
Mr. KAMAL KUMAR AGRAWALNon-Executive - Independent Director
Ms. AMITA MIRAJKARNon-Executive - Independent Director
Mr. Harish Kumar GSChief Executive Officer
Mr. Ankit MaheshwariChief Financial Offcier
Mr. Vikram DhananiCompliance Officer
Mr. Sarang DeshpandeCompany Secretary

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Quick Heal Technologies Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

30

Annual reports

11

Investor Presentation and earnings call

3

May 2026Transcript AI SummaryPPTREC
Oct 2025Transcript AI SummaryPPTREC

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

9

Final dividend30 Aug 2024 · ex-date₹3
Final dividend28 Jul 2023 · ex-date₹2.5
Final dividend18 Aug 2022 · ex-date₹4.5
Dividend dividend29 Jul 2021 · ex-date₹4
Interim dividend2 Mar 2020 · ex-date₹4
Final dividend5 Jul 2019 · ex-date₹2
Final dividend31 Jul 2018 · ex-date₹3
Dividend dividend3 Aug 2017 · ex-date₹2.5
Dividend dividend21 Jul 2016 · ex-date₹2.5

1

Board meeting to consider results30 Jul 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

26 announcementsExport CSV

1 Oct 2026, 3:24 pmCompany Update

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of ESOP / ESPS PDF

16 Sept 2026, 7:23 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

16 Sept 2026, 12:43 pmCompany Update

Clarification On Increase In Volume

General PDF

16 Sept 2026, 11:02 amCompany Update

Clarification sought from Quick Heal Technologies Ltd

Clarification

7 Sept 2026, 1:06 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

3 Sept 2026, 2:48 pmCompany Update

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of ESOP / ESPS PDF

1 Sept 2026, 5:31 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

27 Aug 2026, 3:26 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

Date	Category	Subject	Filing
1 Oct 2026, 3:24 pm	Company Update Allotment of ESOP / ESPS	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS	PDF
16 Sept 2026, 7:23 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management

Loading announcements…

₹ Cr	Mar 2016	Mar 2017	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	78	36	61	71	99	127	31	18	-22	15
	-163	-73	-37	148	-92	79	185	6	16	-26
	189	-20	-24	-221	0	-214	-212	2	-10	3
Net cash flow	104	-57	1	-3	6	-9	4	26	-17	-8
Free cash flow	—	—	—	—	90	121	27	11	-37	-0
CFO / Operating profit %	—	—	48%	75.8%	69.7%	118.7%	—	103.7%	—	—

Quick Heal Technologies Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Investor Presentation and earnings call

Events

Dividends9

Board meetings1

Announcements

Ratio timeline

Not in the F&O segment

Dividends9

Board meetings1

No fund holdings on record

Announcements

Annual reports

Investor Presentation and earnings call

Quarterly record

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

9

1

9

1